Krebs Biochemicals & Industr Q4 Results

  • BSE: 524518
  • NSE: KREBSBIO
  • ISIN: INE268B01013
  • Sector: Biotechnology & Drugs
BSE
98.5315.81 (19.11%)
Volume56.77 K
Updated: Mon 25 Nov, 2024 | 15:47:55
NSE
98.7616.46 (20.00%)
Volume1.01 L
Updated: Mon 25 Nov, 2024 | 15:27:42
Today: 82.71
99.26
52-Wk: 60.00
121.50

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Krebs Biochemicals & Industr Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 11.979.09-%11.46-%
    Selling/ General/ Admin Expenses Total 3.883.91-%4.51-%
    Depreciation/ Amortization 1.671.69-%1.48-%
    Other Operating Expenses Total 8.326.54-%8.43-%
    Total Operating Expense 16.7613.77-%17.56-%
    Operating Income -4.79-4.68-%-6.10-%
    Net Income Before Taxes -5.85-5.55-%-6.94-%
    Net Income -5.85-5.55-%-6.94-%
    Diluted Normalized EPS -2.72-2.58-%-3.06-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts